Through the Center for Mechanism-Based Therapies at Memorial Sloan Kettering Cancer Center, investigators are conducting a range of early-stage studies assessing innovative targeted and immunological therapies. In the field of cancer research, scientists are increasingly using the techniques of molecular biology to identify specific proteins, genes, or other molecules that influence cancer growth. Scientists are designing drugs to inhibit cancer growth by targeting these molecules or by enhancing the ability of the immune system to fight cancer cells. By homing in on a specific target driving a patient's cancer growth, these new agents often have fewer side effects than conventional chemotherapy.
What Does This Mean for Patients?
The Center for Mechanism-Based Therapies expands patients' access to promising new agents based on the latest medical advances. Our goal is to match these drugs with the patients who may benefit from their potential effectiveness.
Phase I Studies
At Memorial Sloan Kettering, phase I clinical trials are conducted by researchers in the following clinics:
Researchers in these clinics have created dedicated treatment areas for patients under the care of clinical trials.
View Phase I Clinical Trials at Memorial Sloan Kettering
View a list of phase I clinical trials enrolling patients at Memorial Sloan Kettering.